This unique test analyses a specific group of genes that are known to be involved in drug metabolism for a broad range of medications used in the treatment of mental health conditions. The Neuropharmagen report provides detailed interpretation and prescribing recommendations for many antidepressants, antipsychotics, anxiolytics/hypnotics ADHD medications and stabilizers and anticonvulsants.
Add to cart
Fragile X syndrome is a genetic condition that can cause a range of learning and developmental problems. These can include: intellectual disability hyperactivity or attention deficit disorder (ADD) anxiety autism spectrum disorder seizures hypotonia Some children with fragile X may also have mildly characteristic features such as prominent ears. Fragile X is more common in […]
Mitochondrial disorders, including Leber Hereditary Neuropathy (LHON) and Mitochondrial Encephalomyopathies (MELAS, MERRF and NARP) are detected with massively parallel, next generation sequencing of the Mitochondrial DNA. Although DNA-based testing provides highly accurate genotyping, rare diagnostic errors may occur. Examples include misinterpretation because of polymorphisms or rare genetic variants, blood transfusion, mislabeled specimens or erroneous representation […]